Although we did not have data available in our T1D group to directly compare the diabetes symptoms scores, a systematic review evaluating QOL in children with T1D using either multiple daily injections or continuous subcutaneous insulin infusion regimen found neither group with T1D demonstrated a significant change in healthcare-related quality of life over time [9]. The gene discussed is INS; the disease is diabetes mellitus.